Literature DB >> 4018911

Prevalence of polyps in an autopsy series from areas with varying incidence of large-bowel cancer.

J C Clark, Y Collan, T J Eide, J Estève, S Ewen, N M Gibbs, O M Jensen, E Koskela, R MacLennan, J G Simpson.   

Abstract

The results of this multicentre autopsy study emphasize the relationship between the prevalence of adenomas and the incidence of large-bowel cancer. The highest proportion of autopsies with adenomas was observed in the area with the highest incidence of large-bowel cancer. The segmental distribution of adenomas within the colon was found to be similar to the site distribution of cancer. However, the lowest proportion of adenomas was found in the rectum, the segment in which cancer is most frequent. The latter finding suggests that either the adenoma-carcinoma sequence is a less important pathway in the pathogenesis of rectal cancer, or that more rectal than colonic adenomas become malignant. The high proportion of hyperplastic polyps in the rectum, and statistically significant regional differences following the same patterns as the incidence of rectal cancer suggest that there could be at least an indirect relationship between hyperplastic polyps and cancer of the rectum. Adenomas of both colon and rectum were more frequent in men than in women, contrary to findings with colon cancer. However, as for colon cancer, the sex ratio of adenomas changed with age, from slightly below unity in persons under 65, to above unity for those aged 65 and over. A major difficulty that emerged was the histological identification of "polyps" because of the degree of autolysis of epithelial cells in the mucous membrane, and this difficulty largely contributed to the poor consistency of histological reporting. Regular consistency surveys of histological preparations should be recommended in any type of multicentre study in which histological examination is included.

Entities:  

Mesh:

Year:  1985        PMID: 4018911     DOI: 10.1002/ijc.2910360209

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  62 in total

1.  Cost-effectiveness of computed tomographic colonography screening for colorectal cancer in the medicare population.

Authors:  Amy B Knudsen; Iris Lansdorp-Vogelaar; Carolyn M Rutter; James E Savarino; Marjolein van Ballegooijen; Karen M Kuntz; Ann G Zauber
Journal:  J Natl Cancer Inst       Date:  2010-07-27       Impact factor: 13.506

2.  How should individuals with a false-positive fecal occult blood test for colorectal cancer be managed? A decision analysis.

Authors:  Ulrike Haug; Amy B Knudsen; Karen M Kuntz
Journal:  Int J Cancer       Date:  2012-03-29       Impact factor: 7.396

3.  A hierarchical non-homogenous Poisson model for meta-analysis of adenoma counts.

Authors:  Carolyn M Rutter; Onchee Yu; Diana L Miglioretti
Journal:  Stat Med       Date:  2007-01-15       Impact factor: 2.373

4.  Adenoma screening and colorectal cancer.

Authors:  A M Pollock; P Quirke
Journal:  BMJ       Date:  1991-07-06

5.  Comparative economic evaluation of data from the ACRIN National CT Colonography Trial with three cancer intervention and surveillance modeling network microsimulations.

Authors:  David J Vanness; Amy B Knudsen; Iris Lansdorp-Vogelaar; Carolyn M Rutter; Ilana F Gareen; Benjamin A Herman; Karen M Kuntz; Ann G Zauber; Marjolein van Ballegooijen; Eric J Feuer; Mei-Hsiu Chen; C Daniel Johnson
Journal:  Radiology       Date:  2011-08-03       Impact factor: 11.105

Review 6.  The differential diagnosis and surveillance of hereditary gastrointestinal polyposis syndromes.

Authors:  Stefan Aretz
Journal:  Dtsch Arztebl Int       Date:  2010-03-12       Impact factor: 5.594

7.  Optimal colorectal cancer screening in states' low-income, uninsured populations—the case of South Carolina.

Authors:  Alex van der Steen; Amy B Knudsen; Frank van Hees; Gailya P Walter; Franklin G Berger; Virginie G Daguise; Karen M Kuntz; Ann G Zauber; Marjolein van Ballegooijen; Iris Lansdorp-Vogelaar
Journal:  Health Serv Res       Date:  2014-10-16       Impact factor: 3.402

8.  Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening.

Authors:  Iris Lansdorp-Vogelaar; Marjolein van Ballegooijen; Ann G Zauber; J Dik F Habbema; Ernst J Kuipers
Journal:  J Natl Cancer Inst       Date:  2009-09-24       Impact factor: 13.506

9.  Contrasting Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening Under Commercial Insurance vs. Medicare.

Authors:  Uri Ladabaum; Ajitha Mannalithara; Joel V Brill; Zachary Levin; Kate M Bundorf
Journal:  Am J Gastroenterol       Date:  2018-06-15       Impact factor: 10.864

10.  High-Intensity Versus Low-Intensity Surveillance for Patients With Colorectal Adenomas: A Cost-Effectiveness Analysis.

Authors:  Reinier G S Meester; Iris Lansdorp-Vogelaar; Sidney J Winawer; Ann G Zauber; Amy B Knudsen; Uri Ladabaum
Journal:  Ann Intern Med       Date:  2019-09-24       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.